Localization of RANKL (Receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues

被引:282
作者
Kartsogiannis, V
Zhou, H
Horwood, NJ
Thomas, RJ
Hards, DK
Quinn, JMW
Niforas, P
Ng, KW
Martin, TJ
Gillespie, MT
机构
[1] St Vincents Hosp, St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia
基金
英国医学研究理事会;
关键词
in situ hybridization; immunohistochemistry; endochondral bone; intramembranous bone; ODF; TRANCE;
D O I
10.1016/S8756-3282(99)00214-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
RANKL (receptor activator of NF kappa B ligand) is a membrane-associated osteoblastic molecule, and along with macrophage-colony-stimulating factor, is crucial for osteoclast formation. RANKL is known to be strongly expressed in osteoblasts and lymphoid tissues. We have sought to determine the skeletal and extraskeletal sites of production of RANKL mRNA and protein using the techniques of in situ hybridization and immunohistochemistry. Expression of RANKL mRNA and protein were determined in the developmental progression of endochondral bone formation in mouse, intramembranous bone formation in a rabbit model (mRNA only), in human giant cell tumors of bone, and at extraskeletal sites in the mouse. RANKL mRNA was expressed in prehypertrophic and hypertrophic chondrocytes at day E15 embryonic mouse long bone, and its expression was maintained at these sites throughout development. In newborn and adult mice, high levels of RANKL mRNA were expressed in mesenchymal cells of the periosteum and in mature osteoblasts, while megakaryocytes within the marrow microenvironment expressed RANKL mRNA from 1 week of age, Immunohistochemical analysis revealed a similar localization pattern of RANKL protein at the sites described. In the intramembranous bone formation model, RANKL mRNA was expressed in mesenchymal cells and in actively synthesizing osteoblasts, but not in flattened lining osteoblasts or late osteocytes, Expression of RANKL mRNA and protein in osteoclasts was variable with those within resorption lacunae showing the strongest signal/staining. Likewise, expression varied in osteoclasts from giant cell tumor of bone with a minority of tartrate-resistant acid phosphatase-positive multinucleated cells having no detectable RANKL mRNA or protein. In extraskeletal tissues, RANKL mRNA and protein were detected in the brain, heart, kidney, skeletal muscle, and skin throughout mouse development, suggesting the possibility of several other functions of the molecule. RANKL was also developmentally regulated, as evidenced by its expression in the intestine, liver, and lung at E15 and newborn mouse but not in the adult. (C) 1999 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:525 / 534
页数:10
相关论文
共 41 条
[1]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[2]   THE ORIGIN AND NATURE OF STROMAL OSTEOCLAST-LIKE MULTINUCLEATED GIANT-CELLS IN BREAST-CARCINOMA - IMPLICATIONS FOR TUMOR OSTEOLYSIS AND MACROPHAGE BIOLOGY [J].
ATHANASOU, NA ;
WELLS, CA ;
QUINN, J ;
FERGUSON, DP ;
HERYET, A ;
MCGEE, JO .
BRITISH JOURNAL OF CANCER, 1989, 59 (04) :491-498
[3]   BONE-RESORPTION BY MACROPHAGE POLYKARYONS OF GIANT-CELL TUMOR OF TENDON SHEATH [J].
ATHANASOU, NA ;
QUINN, J ;
FERGUSON, DJP ;
MCGEE, JO .
BRITISH JOURNAL OF CANCER, 1991, 63 (04) :527-533
[4]  
ATHANASOU NA, 1992, CANCER, V70, P469
[5]  
BOENISCH T, 1989, HDB IMMUNOCHEMICAL S, P16
[6]  
BOLAM JP, 1992, EXPT NEUROANATOMY PR, P2
[7]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[8]  
DANKS JA, 1989, J BONE MINER RES, V4, P273
[9]   IN-SITU HYBRIDIZATION OF PARATHYROID HORMONE-RELATED PROTEIN IN NORMAL SKIN, SKIN TUMORS, AND GYNECOLOGICAL CANCERS USING DIGOXIGENIN-LABELED PROBES AND ANTIBODY ENHANCEMENT [J].
DANKS, JA ;
MCHALE, JC ;
CLARK, SP ;
CHOU, ST ;
SCURRY, JP ;
INGLETON, PM ;
MARTIN, TJ .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1995, 43 (01) :5-10
[10]   Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL [J].
Emery, JG ;
McDonnell, P ;
Burke, MB ;
Deen, KC ;
Lyn, S ;
Silverman, C ;
Dul, E ;
Appelbaum, ER ;
Eichman, C ;
DiPrinzio, R ;
Dodds, RA ;
James, IE ;
Rosenberg, M ;
Lee, JC ;
Young, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (23) :14363-14367